TransEnterix, Inc. (TRXC)

2.07
0.03 1.47
AMEX
Prev Close 2.04
Open 2.05
Day Low/High 2.02 / 2.08
52 Wk Low/High 1.58 / 6.98
Volume 1.54M
Exchange AMEX
Shares Outstanding 217.04B
Market Cap 479.66M
Div & Yield N.A. (N.A)

Latest News

TRXC May 17th Options Begin Trading

TRXC May 17th Options Begin Trading

Investors in TransEnterix Inc saw new options begin trading today, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TRXC options chain for the new May 17th contracts and identified one put and one call contract of particular interest.

TransEnterix, Inc. Reports Operating And Financial Results For The Fourth Quarter And Full Year 2018

TransEnterix, Inc. Reports Operating And Financial Results For The Fourth Quarter And Full Year 2018

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the fourth quarter and...

TransEnterix Schedules Fourth Quarter And Fiscal Year 2018 Financial And Operating Results Conference Call For February 26, 2019

TransEnterix Schedules Fourth Quarter And Fiscal Year 2018 Financial And Operating Results Conference Call For February 26, 2019

TransEnterix, Inc. (NYSE American: TRXC) announced today that it plans to release fourth quarter and fiscal year 2018 financial and operating results before the market opens on Tuesday, February 26, 2019.

TRXC March 15th Options Begin Trading

TRXC March 15th Options Begin Trading

Investors in TransEnterix Inc saw new options become available today, for the March 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TRXC options chain for the new March 15th contracts and identified the following call contract of particular interest.

TransEnterix Receives FDA 510(k) Clearance For Senhance Ultrasonic System

TransEnterix Receives FDA 510(k) Clearance For Senhance Ultrasonic System

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced the Company received FDA 510(k) clearance for its Senhance™ Ultrasonic...

TransEnterix Provides Corporate Update

TransEnterix Provides Corporate Update

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today provided a corporate update, including preliminary unaudited revenue for the...

Interesting TRXC Put And Call Options For February 2019

Interesting TRXC Put And Call Options For February 2019

Investors in TransEnterix Inc saw new options become available today, for the February 2019 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TRXC options chain for the new February 2019 contracts and identified one put and one call contract of particular interest.

TransEnterix To Present At The 37th Annual J. P. Morgan Healthcare Conference

TransEnterix To Present At The 37th Annual J. P. Morgan Healthcare Conference

TransEnterix, Inc. (NYSE American:TRXC) announced today that Todd M.

Interesting TRXC Put And Call Options For July 2019

Interesting TRXC Put And Call Options For July 2019

Investors in TransEnterix Inc saw new options begin trading today, for the July 2019 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 242 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

TransEnterix Named To Deloitte's Technology Fast 500

TransEnterix Named To Deloitte's Technology Fast 500

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced its naming to Deloitte's 2018 Technology Fast 500 TM, an annual ranking...

TransEnterix, Inc. Reports Operating And Financial Results For The Third Quarter 2018

TransEnterix, Inc. Reports Operating And Financial Results For The Third Quarter 2018

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the third quarter 2018.

TransEnterix To Present At The Stifel 2018 Healthcare Conference

TransEnterix To Present At The Stifel 2018 Healthcare Conference

TransEnterix, Inc. (NYSE American:TRXC) announced today that Todd M.

Beware the Roving Bear: Cramer's 'Mad Money' Recap (Wednesday 9/12/18)

Beware the Roving Bear: Cramer's 'Mad Money' Recap (Wednesday 9/12/18)

Jim Cramer says September brings out the bear in the market and it's searching how to take your money away. Stay diversified and stay the course, he says.

Prudential, Roku, CRISPR Therapeutics: 'Mad Money' Lightning Round

Prudential, Roku, CRISPR Therapeutics: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Prudential, Roku, CRISPR Therapeutics, Oneok, At Home Group, iQIYI, and TransEnterix.

AbbVie, Greendot, Sherwin-Williams: 'Mad Money' Lightning Round

AbbVie, Greendot, Sherwin-Williams: 'Mad Money' Lightning Round

Jim Cramer takes a look at AbbVie, Greendot, Sherwin-Williams, Visteon, TransEnterix, Duke Energy, Buckeye Partners, Arch Coal and more.

More Than One Way to Win: Cramer's 'Mad Money' Recap (Thursday 8/9/18)

More Than One Way to Win: Cramer's 'Mad Money' Recap (Thursday 8/9/18)

Jim Cramer says that in good markets there are always multiple ways for investors to win.

TransEnterix Schedules Third Quarter 2018 Financial And Operating Results Conference Call For November 8, 2018

TransEnterix Schedules Third Quarter 2018 Financial And Operating Results Conference Call For November 8, 2018

TransEnterix, Inc. (NYSE American: TRXC) announced today that it plans to release third quarter 2018 financial and operating results after the market closes on Thursday, November 8, 2018.

Todd Pope, TransEnterix President And CEO. (Photo: Business Wire)

Todd Pope, TransEnterix President And CEO. (Photo: Business Wire)

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, congratulates its President and Chief Executive Officer, Todd M.

TransEnterix To Showcase First Digital Laparoscopic Surgical Platform, The Senhance Surgical System, At American College Of Surgeons Clinical Congress 2018

TransEnterix To Showcase First Digital Laparoscopic Surgical Platform, The Senhance Surgical System, At American College Of Surgeons Clinical Congress 2018

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced demonstrations of its Senhance™ Surgical System at the American...

TransEnterix Receives FDA 510(k) Clearance For 3mm Diameter Instruments

TransEnterix Receives FDA 510(k) Clearance For 3mm Diameter Instruments

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Company received FDA 510(k) clearance for 3 millimeter...

TransEnterix Provides Corporate Update

TransEnterix Provides Corporate Update

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today provided a corporate update, including preliminary unaudited revenue for the...

TransEnterix Receives CE Mark Approval For Senhance Ultrasonic Instrument System

TransEnterix Receives CE Mark Approval For Senhance Ultrasonic Instrument System

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Company received CE Mark approval for its Senhance...

TransEnterix Acquires Assets, Intellectual Property And Retains R&D Team From MST Medical Surgery Technologies

TransEnterix Acquires Assets, Intellectual Property And Retains R&D Team From MST Medical Surgery Technologies

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced that it has acquired substantially all of the assets of MST Medical...

TransEnterix To Participate In Two Upcoming Healthcare Conferences

TransEnterix To Participate In Two Upcoming Healthcare Conferences

TransEnterix, Inc. (NYSE American:TRXC) announced today that TransEnterix will participate in two upcoming healthcare conferences: Todd M.

TransEnterix Announces FDA 510(k) Submission For Senhance Ultrasonic Instrument System

TransEnterix Announces FDA 510(k) Submission For Senhance Ultrasonic Instrument System

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced the Company filed a FDA 510(k) submission for its Senhance Ultrasonic...

TransEnterix, Inc. Appoints Eric Smith As Chief Commercial Officer

TransEnterix, Inc. Appoints Eric Smith As Chief Commercial Officer

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that Eric Smith has been named Chief Commercial Officer,...

TransEnterix To Present At The 13th Annual Wells Fargo Securities Healthcare Conference

TransEnterix To Present At The 13th Annual Wells Fargo Securities Healthcare Conference

TransEnterix, Inc. (NYSE American:TRXC) announced today that Todd M.

TransEnterix, Inc. Reports Operating And Financial Results For The Second Quarter 2018

TransEnterix, Inc. Reports Operating And Financial Results For The Second Quarter 2018

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the second quarter 2018.

TheStreet Quant Rating: D- (Sell)